Annual EBITDA:
-$261.52M-$102.47M(-64.43%)Summary
- As of today, PHAT annual EBITDA is -$261.52 million, with the most recent change of -$102.47 million (-64.43%) on December 31, 2024.
- During the last 3 years, PHAT annual EBITDA has fallen by -$124.95 million (-91.49%).
- PHAT annual EBITDA is now -20411.53% below its all-time high of -$1.27 million, reached on December 31, 2018.
Performance
PHAT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$58.12M+$17.95M(+23.59%)Summary
- As of today, PHAT quarterly EBITDA is -$58.12 million, with the most recent change of +$17.95 million (+23.59%) on June 30, 2025.
- Over the past year, PHAT quarterly EBITDA has increased by +$15.37 million (+20.91%).
- PHAT quarterly EBITDA is now -20221.68% below its all-time high of -$286.00 thousand, reached on September 30, 2018.
Performance
PHAT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$256.75M+$15.37M(+5.65%)Summary
- As of today, PHAT TTM EBITDA is -$256.75 million, with the most recent change of +$15.37 million (+5.65%) on June 30, 2025.
- Over the past year, PHAT TTM EBITDA has dropped by -$18.43 million (-7.73%).
- PHAT TTM EBITDA is now -89674.48% below its all-time high of -$286.00 thousand, reached on September 30, 2018.
Performance
PHAT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PHAT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -64.4% | +20.9% | -7.7% |
| 3Y3 Years | -91.5% | -28.9% | -70.2% |
| 5Y5 Years | -4.2% | -194.1% | -52.1% |
PHAT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -91.5% | at low | -104.3% | +23.6% | -86.1% | +5.7% |
| 5Y | 5-Year | -110.6% | at low | -104.3% | +23.6% | -106.8% | +5.7% |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | +40.1% | >-9999.0% | +5.7% |
PHAT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$58.12M(+23.6%) | -$256.75M(+5.6%) |
| Mar 2025 | - | -$76.07M(-36.7%) | -$272.12M(-4.1%) |
| Dec 2024 | -$261.52M(-64.4%) | -$55.66M(+16.8%) | -$261.52M(+3.9%) |
| Sep 2024 | - | -$66.90M(+9.0%) | -$272.21M(-14.2%) |
| Jun 2024 | - | -$73.48M(-12.2%) | -$238.33M(-21.6%) |
| Mar 2024 | - | -$65.47M(+1.3%) | -$196.07M(-23.3%) |
| Dec 2023 | -$159.05M(+6.3%) | -$66.36M(-101.0%) | -$159.05M(-15.3%) |
| Sep 2023 | - | -$33.02M(-5.7%) | -$137.97M(+5.9%) |
| Jun 2023 | - | -$31.23M(-9.8%) | -$146.59M(+8.6%) |
| Mar 2023 | - | -$28.45M(+37.2%) | -$160.47M(+5.5%) |
| Dec 2022 | -$169.80M | -$45.28M(-8.7%) | -$169.80M(-7.9%) |
| Sep 2022 | - | -$41.64M(+7.7%) | -$157.44M(-4.4%) |
| Jun 2022 | - | -$45.10M(-19.4%) | -$150.84M(-7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$37.78M(-14.8%) | -$140.91M(-3.2%) |
| Dec 2021 | -$136.57M(-10.0%) | -$32.92M(+6.1%) | -$136.57M(+12.4%) |
| Sep 2021 | - | -$35.05M(+0.3%) | -$155.98M(-1.5%) |
| Jun 2021 | - | -$35.16M(-5.1%) | -$153.66M(-11.1%) |
| Mar 2021 | - | -$33.45M(+36.1%) | -$138.26M(-11.4%) |
| Dec 2020 | -$124.16M(+50.5%) | -$52.32M(-59.8%) | -$124.16M(+26.4%) |
| Sep 2020 | - | -$32.73M(-65.6%) | -$168.81M(+16.5%) |
| Jun 2020 | - | -$19.76M(-2.1%) | -$202.19M(+24.9%) |
| Mar 2020 | - | -$19.35M(+80.0%) | -$269.06M(-7.7%) |
| Dec 2019 | -$250.95M(>-9900.0%) | -$96.96M(-46.6%) | -$249.71M(-63.0%) |
| Sep 2019 | - | -$66.12M(+23.7%) | -$153.22M(-75.3%) |
| Jun 2019 | - | -$86.63M(>-9900.0%) | -$87.39M(>-9900.0%) |
| Dec 2018 | -$1.27M | -$479.00K(-67.5%) | -$765.00K(-167.5%) |
| Sep 2018 | - | -$286.00K | -$286.00K |
FAQ
- What is Phathom Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Phathom Pharmaceuticals, Inc.?
- What is Phathom Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Phathom Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Phathom Pharmaceuticals, Inc.?
- What is Phathom Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Phathom Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Phathom Pharmaceuticals, Inc.?
- What is Phathom Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Phathom Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of PHAT is -$261.52M
What is the all-time high annual EBITDA for Phathom Pharmaceuticals, Inc.?
Phathom Pharmaceuticals, Inc. all-time high annual EBITDA is -$1.27M
What is Phathom Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, PHAT annual EBITDA has changed by -$102.47M (-64.43%)
What is Phathom Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of PHAT is -$58.12M
What is the all-time high quarterly EBITDA for Phathom Pharmaceuticals, Inc.?
Phathom Pharmaceuticals, Inc. all-time high quarterly EBITDA is -$286.00K
What is Phathom Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, PHAT quarterly EBITDA has changed by +$15.37M (+20.91%)
What is Phathom Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of PHAT is -$256.75M
What is the all-time high TTM EBITDA for Phathom Pharmaceuticals, Inc.?
Phathom Pharmaceuticals, Inc. all-time high TTM EBITDA is -$286.00K
What is Phathom Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, PHAT TTM EBITDA has changed by -$18.43M (-7.73%)